Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

KW-2170: in vitro and in vivo antitumor activity of a new pyrazoloacridone

April 30, 1998

New polythiophene antitumor agents for treating slow-growing tumors

April 29, 1998

CellPro and Corixa terminate cancer immunotherapy effort

April 29, 1998

Telomerase-deficient mice have impaired tissue and organ function

April 28, 1998

Toagosei presents several related antitumor series

April 28, 1998

Baccatin derivatives with antitumor activity developed at Tanabe Seiyaku

April 27, 1998

Sparta licenses drug delivery technology for temozolomide to Schering-Plough

April 27, 1998

Pacific will begin safety trial of BOPP photodynamic therapy

April 27, 1998

Immunosuppressive MDR inhibitor isolated from bacterial species

April 24, 1998

Kyowa Hakko develops new antitumor agents from DC-89

April 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...